Michael J. Farrell - Nov 11, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Nov 11, 2021
Transactions value $
-$2,269,844
Form type
4
Date filed
11/15/2021, 12:18 PM
Previous filing
Oct 4, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability -$2.27M -8.75K -2.06% $259.47 416K Nov 11, 2021 Direct F1, F2
holding RMD ResMed Common Stock 8.97K Nov 11, 2021 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted for dates 11/14/2018, 11/21/2019 and 11/19/2020.
F2 Includes 94.5633 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.